This article by Jillian Spencer and Patrick Clarke examines the Australian Professional Association for Trans Health (AusPATH) and argues that it operates more as an activist group than a professional medical body, despite its strong influence on health policy. Originally limited to registered health professionals, AusPATH now admits members without medical qualifications, including activists, and elevates “lived experience” to the level of clinical expertise.
The authors contend that AusPATH’s position statements, especially on puberty blockers, are misleading and fail to reflect well-established concerns in the scientific literature. Examples include comparing puberty blockers for gender dysphoria to treatment for precocious puberty—two very different conditions—while overlooking known risks such as reduced bone density, infertility, impaired sexual function, and potential cognitive effects.
The article highlights that AusPATH has repeatedly described puberty blockers as “safe” and “lifesaving,” and claimed they “buy time to think” or have strong evidence of benefit, despite reviews by bodies such as the UK’s Cass Review, the Finnish and Swedish health authorities, and NICE finding low-quality or insufficient evidence to support these claims. The authors warn that more than 90% of children started on blockers proceed to cross-sex hormones, undermining the “pause” narrative, and stress that no robust evidence supports suicide-prevention claims.
They conclude that clinicians and policymakers should critically assess AusPATH’s statements rather than accept them at face value, prioritising evidence-based medicine over activist influence in the sensitive and poorly evidenced field of youth gender medicine.
